Vaccines as treatment for melanoma: an update review - Takeaways - MDSpire

Vaccines as treatment for melanoma: an update review

  • By

  • Jinjue Zhang

  • Qing Cao

  • Ying Cen

  • Ling Zhang

  • Junjie Chen

  • June 9, 2026

  • 0 min

Share

  • 1

    Therapeutic vaccines aim to prime the immune system against melanoma, potentially eradicating recurrent disease or delaying progression.

  • 2

    Sixteen distinct vaccine methodologies have been evaluated in randomized phase III clinical trials for melanoma.

  • 3

    Talimogene laherparevec (T-VEC) is the only FDA-approved vaccine for melanoma treatment, demonstrating acceptable safety but limited clinical efficacy.

  • 4

    Vaccines may enhance therapeutic potential when combined with other immunomodulatory agents that target tumor resistance mechanisms.

  • 5

    Melanoma vaccines are designed to induce a targeted T-cell response, contributing to the prevention of cancer recurrence.

Original Source(s)

Related Content